Breast Reconstruction in IN
Breast Reconstruction in IN section, includes general infrmation about Breast Reconstruction Procedure, Breast Reconstruction IN Local News, Breast Reconstruction IN Surgeon Locator and other Breast Reconstruction related material.
Breast Reconstruction Procedure
This procedure is designed for women who underwent breast amputation after breast cancer or other conditions. Newer techniques allow the surgeon to create a breast which is very similar to the natural one. The reconstruction can be done during the amputation procedure, or a few months or even a year afterwards.
There are a number of implants: the most widely used are silicon implants which have silicon surface and filling. They come in different sizes and shapes.
Becker implants are made of a thick silicon surface (35%-50%) and a solution filling. The advantage of this implant is the ability to adjust its shape to the woman's body. It can also serve as a skin stretcher. There are also implants with a thin silicon surface and a solution filling, which are less used.
The operation can be divided into 2 main categories: (a) a stretcher is inserted, then replaced with an implant; (b) the reconstruction is made from another body tissue.
The most common reconstruction is performed with a stretcher and an implant. After amputation a balloon (stretcher) is inserted under the skin and chest muscles. It has a special valve which can be filled from outside. The implant is being filled gradually with a special solution, until the skin has sufficiently stretched for inserting the implant. It takes another 3-6 months until the breast has acquired its final shape, then the nipple can be reconstructed as well.
Becker implants: sometimes during amputation the skin can be preserved. That would eliminate the need for a stretcher, and a permanent implant (Becker) can be inserted right away.
The breast can also be reconstructed with body tissue from areas with extra skin and fat, like the tummy, buttocks and back. The tissue being removed is called "a flap". Common sites to acquire the flap are the lower tummy and the lotissimus dorsi muscle from the back.
This procedure can be complicated due to implant infection, a contraction of a surface of an implant, silicon leaks and anesthetic complications.
You'll need to stay in hospital 2-7 days after the surgery, while you may feel pain and weakness for a week or two. Complete recovery may take up to 6 weeks, depending on the surgery. You may have an unusual sensation in the breast that would usually disappear over time. In most cases there could be a slight asymmetry between the breasts, however, most women report a significant improvement in their social life and self esteem.
Other Breast Reconstruction Procedures
All Breast Procedures
Breast Reconstruction IN (current)
IN Breast Lift
IN Breast Implants
IN Implant Removal
IN Armpit Incision
More IN info...
India Regions Regions of IndiaIndia is administratively divided into 28 states and 7 union territories. The states are broadly demarcated on linguistic lines. They vary in size; the larger ones are bigger and more diverse than some countries of Europe. The union territories are smaller than the states - sometimes they are just one city - and they have much less autonomy.
These states and union territories are grouped by convention into the following regions.
India Cities India -citiesBelow is a selection of nine of India's most notable cities. Other cities can be found under their specific regions.
Delhi — the capital of India for a thousand years and the heart of Northern India.
Plastic Surgery News...
- Abiomed Inc. (NASDAQ: ABMD) recently received a proposed National Coverage Decision (NCD) from the Centers for Medicare & Medicaid Services (CMS) for its AbioCor® Total Replacement Heart."This proposed decision is a positive development for the advancement of our AbioCor program in the United States," said Michael R. Minogue, Chairman, President and CEO of Abiomed.
- Novartis Pharmaceuticals UK Limited in agreement with the Committee for Medicinal Products for Human Use (CHMP) is informing healthcare professionals of an increased risk of peripheral neuropathy in chronic hepatitis B patients treated with Sebivo® (telbivudine). This was recently highlighted by the EMEA in a public statement (see link above to view a related NeLM news item). A letter from the company states the following:
• Peripheral neuropathy has been uncommonly reported in telbivudine-treated patients when used as monotherapy.
• The risk of peripheral neuropathy is increased when telbivudine and pegylated interferon alfa-2a are combined. Such increased risk cannot be excluded for other interferons alfa (pegylated or standard).
• If peripheral neuropathy is suspected, treatment with telbivudine should be reconsidered.
• The benefit of telbivudine in combination with interferon alfa (pegylated or standard) is not currently established.
• Sebivo is indicated for the treatment of chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis as monotherapy only.
The Sebivo SPC is currently being updated to include this information (the SPC had not been updated on the EMC at the time of writing).